Search Results - "Broder, Michael S."

Epidemiology of AL amyloidosis: a real-world study using US claims data by Quock, Tiffany P., Yan, Tingjian, Chang, Eunice, Guthrie, Spencer, Broder, Michael S.

“…Amyloid light-chain (AL) amyloidosis is a rare disease caused by extracellular deposition of misfolded immunoglobulin light chains. This study aimed to provide…”
Get full text

FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age by Munro, Malcolm G, Critchley, Hilary O.D, Broder, Michael S, Fraser, Ian S

“…Abstract There is general inconsistency in the nomenclature used to describe abnormal uterine bleeding (AUB), in addition to a plethora of potential…”
Get full text

Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health Study by Parker, William H., Broder, Michael S., Chang, Eunice, Feskanich, Diane, Farquhar, Cindy, Liu, Zhimae, Shoupe, Donna, Berek, Jonathan S., Hankinson, Susan, Manson, JoAnn E.

“…To report long-term health outcomes and mortality after oophorectomy or ovarian conservation. We conducted a prospective, observational study of 29,380 women…”
Get full text

Impact of early detection on cancer curability: A modified Delphi panel study by Schwartzberg, Lee, Broder, Michael S, Ailawadhi, Sikander, Beltran, Himisha, Blakely, L Johnetta, Budd, G Thomas, Carr, Laurie, Cecchini, Michael, Cobb, Patrick, Kansal, Anuraag, Kim, Ashley, Monk, Bradley J, Wong, Deborah J, Campos, Cynthia, Yermilov, Irina

“…Expert consensus on the potential benefits of early cancer detection does not exist for most cancer types. We convened 10 practicing oncologists using a…”
Get full text

Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States by Lewiecki, E Michael, Ortendahl, Jesse D, Vanderpuye‐Orgle, Jacqueline, Grauer, Andreas, Arellano, Jorge, Lemay, Jeffrey, Harmon, Amanda L, Broder, Michael S, Singer, Andrea J

“…ABSTRACT In the United States, osteoporosis affects over 10 million adults, has high societal costs ($22 billion in 2008), and is currently being…”
Get full text

Corticosteroid-related adverse events in patients with giant cell arteritis: a claims-based analysis by Broder, Michael S., MD, MSHS, Sarsour, Khaled, PhD, MPH, Chang, Eunice, PhD, Collinson, Neil, PhD, Tuckwell, Katie, PhD, Napalkov, Pavel, MD, Klearman, Micki, MD

“…Abstract Objective Corticosteroids (CS) are standard treatment for giant cell arteritis (GCA), but concerns persist over toxicities associated with long-term…”
Get full text

Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR:A systematic literature review by Broder, Michael S, Beenhouwer, David, Strosberg, Jonathan R, Neary, Maureen P, Cherepanov, Dasha

“…AIM:To review literature on efficacy and safety of octreotide-long-acting repeatable(LAR)used at doses higher than the Food and Drug…”
Get full text

Mechanical ventilation in idiopathic pulmonary fibrosis: a nationwide analysis of ventilator use, outcomes, and resource burden by Mooney, Joshua J, Raimundo, Karina, Chang, Eunice, Broder, Michael S

“…Idiopathic pulmonary fibrosis (IPF) is associated with increased risk of respiratory-related hospitalizations. Studies suggest mechanical ventilation (MV) use…”
Get full text

Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database by Broder, Michael S, Cai, Beilei, Chang, Eunice, Neary, Maureen P

“…As reported in Surveillance, Epidemiology, and End Results (SEER) data, US incidence and prevalence of neuroendocrine tumors (NET) has increased over recent…”
Get full text

Systematic bias in predictions of new drugs' budget impact: analysis of a sample of recent US drug launches by Broder, Michael S., Zambrano, Jenelle M., Lee, Jackie, Marken, Richard S.

“…Objective: Expectations about the budget impact of new drug launches may affect payer behavior and ultimately consumer costs. Therefore, we evaluated the…”
Get full text

Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic by Das, Ashis K., Chang, Eunice, Paydar, Caleb, Broder, Michael S., Orroth, Kate K., Cordey, Myriam

“…Introduction Limited access to healthcare during the COVID-19 pandemic prompted patients to seek care using telehealth. In this study, we assessed whether…”
Get full text

Predictive factors associated with carcinoid syndrome in patients with gastrointestinal neuroendocrine tumors by Cai, Beilei, Broder, Michael S, Chang, Eunice, Yan, Tingjian, Metz, David C

“…AIM To discover unknown factors associated with carcinoid syndrome(CS) with the goal of earlier diagnosis of CS.METHODS In this retrospective case-control…”
Get full text

Correction: Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic by Das, Ashis K., Chang, Eunice, Paydar, Caleb, Broder, Michael S., Orroth, Kate K., Cordey, Myriam

Get full text

The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First‐Line Hypomethylating Agents Fail by Cogle, Christopher R., Kurtin, Sandra E., Bentley, Tanya G. K., Broder, Michael S., Chang, Eunice, Megaffin, Scott, Fruchtman, Steven, Petrone, Michael E., Mukherjee, Sudipto

“…Background Although hypomethylating agents (HMAs) are effective and approved therapies for patients with myelodysplastic syndromes (MDS), many patients do not…”
Get full text

In-hospital mortality in amyloid light chain amyloidosis: analysis of the Premier Healthcare Database by Quock, Tiffany P, D'Souza, Anita, Broder, Michael S, Bognar, Katalin, Chang, Eunice, Tarbox, Marian H

“…Describe the clinical and economic burden of hospitalizations for amyloid light chain (AL) amyloidosis. This retrospective analysis used nationally…”
Get full text

Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy by Dana, Reza, Farid, Marjan, Gupta, Preeya K, Hamrah, Pedram, Karpecki, Paul, McCabe, Cathleen M, Nijm, Lisa, Pepose, Jay S, Pflugfelder, Stephen, Rapuano, Christopher J, Saini, Arvind, Gibbs, Sarah N, Broder, Michael S

“…Abstract Background Neurotrophic keratopathy (NK) is a relatively uncommon, underdiagnosed degenerative corneal disease that is caused by damage to the…”
Get full text

Increased Clinical and Economic Burden Associated With Peripheral Intravenous Catheter–Related Complications: Analysis of a US Hospital Discharge Database by Lim, Sangtaeck, Gangoli, Gaurav, Adams, Erica, Hyde, Robert, Broder, Michael S., Chang, Eunice, Reddy, Sheila R., Tarbox, Marian H., Bentley, Tanya, Ovington, Liza, Danker, Walt

“…The burden of complications associated with peripheral intravenous use is underevaluated, in part, due to the broad use, inconsistent coding, and lack of…”
Get full text

Ovarian conservation at the time of hysterectomy for benign disease by PARKER, William H, BRODER, Michael S, ZHIMEI LIU, SHOUPE, Donna, FARQUHAR, Cindy, BEREK, Jonathan S

“…Prophylactic oophorectomy is often recommended concurrent with hysterectomy for benign disease. The optimal age for this recommendation in women at average…”
Get full text

Review of the confusion in current and historical terminology and definitions for disturbances of menstrual bleeding by Woolcock, Jane G., M.B.B.S, Critchley, Hilary O.D., M.D, Munro, Malcolm G., M.D, Broder, Michael S., M.D, Fraser, Ian S., M.D

“…Objective There has been increasing recent recognition of the worldwide confusion in the terminology and definitions for abnormalities of menstrual and uterine…”
Get full text

Validity and Reliability of Value Assessment Frameworks for New Cancer Drugs by Bentley, Tanya G.K., PhD, Cohen, Joshua T., PhD, Elkin, Elena B., PhD, Huynh, Julie, MD, Mukherjea, Arnab, DrPH, MPH, Neville, Thanh H., MD, MSHS, Mei, Matthew, MD, Copher, Ronda, PhD, Knoth, Russell, PhD, Popescu, Ioana, MD, MPH, Lee, Jackie, BS, Zambrano, Jenelle M., DNP, CNS, RN, Broder, Michael S., MD, MSHS

“…Abstract Background Several organizations have developed frameworks to systematically assess the value of new drugs. These organizations include the American…”
Get full text